請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/40282完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 謝學真(Hsyue-Jen Hsieh) | |
| dc.contributor.author | Hung-Hsiun Chang | en |
| dc.contributor.author | 張弘勳 | zh_TW |
| dc.date.accessioned | 2021-06-14T16:43:59Z | - |
| dc.date.available | 2010-08-04 | |
| dc.date.copyright | 2008-08-04 | |
| dc.date.issued | 2008 | |
| dc.date.submitted | 2008-07-30 | |
| dc.identifier.citation | Adams, T.E., and Huntington, J.A. (2006). Thrombin-cofactor interactions: structural insights into regulatory mechanisms. Arteriosclerosis, Thrombosis, and Vascular Biology 26, 1738-1745.
Awolesi, M.A., Sessa, W.C., and Sumpio, B.E. (1995). Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells. The Journal of Clinical Investigation 96, 1449-1454. Baker, S.J. (2007). PTEN enters the nuclear age. Cell 128, 25-28. Behrendt, D., and Ganz, P. (2002). Endothelial function. From vascular biology to clinical applications. The American Journal of Cardiology 90, 40L-48L. Berliner, J.A., and Heinecke, J.W. (1996). The role of oxidized lipoproteins in atherogenesis. Free Radical Biology & Medicine 20, 707-727. Bonner, J.C. (1994). Regulation of platelet-derived growth factor (PDGF) and alveolar macrophage-derived PDGF by alpha 2-macroglobulin. Annals of the New York Academy of Sciences 737, 324-338. Bourin, M.C., Lundgren-Akerlund, E., and Lindahl, U. (1990). Isolation and characterization of the glycosaminoglycan component of rabbit thrombomodulin proteoglycan. The Journal of Biological Chemistry 265, 15424-15431. Bouton, M.C., Venisse, L., Richard, B., Pouzet, C., Arocas, V., and Jandrot-Perrus, M. (2007). Protease nexin-1 interacts with thrombomodulin and modulates its anticoagulant effect. Circulation Research 100, 1174-1181. Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72, 248-254. Bruemmer, D., Collins, A.R., Noh, G., Wang, W., Territo, M., Arias-Magallona, S., Fishbein, M.C., Blaschke, F., Kintscher, U., Graf, K., et al. (2003). Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. The Journal of Clinical Investigation 112, 1318-1331. Busse, R., and Fleming, I. (2003). Regulation of endothelium-derived vasoactive autacoid production by hemodynamic forces. Trends in Pharmacological Sciences 24, 24-29. Calnek, D.S., and Grinnell, B.W. (1998). Thrombomodulin-dependent anticoagulant activity is regulated by vascular endothelial growth factor. Experimental Cell Research 238, 294-298. Cheng, J.J., Wung, B.S., Chao, Y.J., and Wang, D.L. (1998). Cyclic strain-induced reactive oxygen species involved in ICAM-1 gene induction in endothelial cells. Hypertension 31, 125-130. Collins, R.G., Velji, R., Guevara, N.V., Hicks, M.J., Chan, L., and Beaudet, A.L. (2000). P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. The Journal of Experimental Medicine 191, 189-194. Conway, E.M., Liu, L., Nowakowski, B., Steiner-Mosonyi, M., and Jackman, R.W. (1994). Heat shock of vascular endothelial cells induces an up-regulatory transcriptional response of the thrombomodulin gene that is delayed in onset and does not attenuate. The Journal of Biological Chemistry 269, 22804-22810. Conway, E.M., Pollefeyt, S., Collen, D., and Steiner-Mosonyi, M. (1997). The amino terminal lectin-like domain of thrombomodulin is required for constitutive endocytosis. Blood 89, 652-661. Conway, E.M., Pollefeyt, S., Cornelissen, J., DeBaere, I., Steiner-Mosonyi, M., Weitz, J.I., Weiler-Guettler, H., Carmeliet, P., and Collen, D. (1999). Structure-function analyses of thrombomodulin by gene-targeting in mice: the cytoplasmic domain is not required for normal fetal development. Blood 93, 3442-3450. Conway, E.M., Van de Wouwer, M., Pollefeyt, S., Jurk, K., Van Aken, H., De Vriese, A., Weitz, J.I., Weiler, H., Hellings, P.W., Schaeffer, P., et al. (2002). The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways. The Journal of Experimental Medicine 196, 565-577. Cully, M., You, H., Levine, A.J., and Mak, T.W. (2006). Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nature Reviews Cancer 6, 184-192. Dittman, W.A., Kumada, T., and Majerus, P.W. (1989). Transcription of thrombomodulin mRNA in mouse hemangioma cells is increased by cycloheximide and thrombin. Proceedings of the National Academy of Sciences of the United States of America 86, 7179-7182. Drake, P.M., Gunn, M.D., Charo, I.F., Tsou, C.L., Zhou, Y., Huang, L., and Fisher, S.J. (2001). Human placental cytotrophoblasts attract monocytes and CD56(bright) natural killer cells via the actions of monocyte inflammatory protein 1alpha. The Journal of Experimental Medicine 193, 1199-1212. Dudek, A.Z., Pennell, C.A., Decker, T.D., Young, T.A., Key, N.S., and Slungaard, A. (1997). Platelet factor 4 binds to glycanated forms of thrombomodulin and to protein C. A potential mechanism for enhancing generation of activated protein C. The Journal of Biological Chemistry 272, 31785-31792. Esmon, C. (2005). Do-all receptor takes on coagulation, inflammation. Nature Medicine 11, 475-477. Esmon, C.T. (2006). Inflammation and the activated protein C anticoagulant pathway. Seminars in Thrombosis and Hemostasis 32 Suppl 1, 49-60. Esmon, C.T., Fukudome, K., Mather, T., Bode, W., Regan, L.M., Stearns-Kurosawa, D.J., and Kurosawa, S. (1999a). Inflammation, sepsis, and coagulation. Haematologica 84, 254-259. Esmon, C.T., Gu, J.M., Xu, J., Qu, D., Stearns-Kurosawa, D.J., and Kurosawa, S. (1999b). Regulation and functions of the protein C anticoagulant pathway. Haematologica 84, 363-368. Eytan, E., Ganoth, D., Armon, T., and Hershko, A. (1989). ATP-dependent incorporation of 20S protease into the 26S complex that degrades proteins conjugated to ubiquitin. Proceedings of the National Academy of Sciences of the United States of America 86, 7751-7755. Fairlie, W.D., Moore, A.G., Bauskin, A.R., Russell, P.K., Zhang, H.P., and Breit, S.N. (1999). MIC-1 is a novel TGF-beta superfamily cytokine associated with macrophage activation. Journal of Leukocyte Biology 65, 2-5. Faxon, D.P., Creager, M.A., Smith, S.C., Jr., Pasternak, R.C., Olin, J.W., Bettmann, M.A., Criqui, M.H., Milani, R.V., Loscalzo, J., Kaufman, J.A., et al. (2004). Atherosclerotic Vascular Disease Conference: Executive summary: Atherosclerotic Vascular Disease Conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation 109, 2595-2604. Frangos, J.A., Eskin, S.G., McIntire, L.V., and Ives, C.L. (1985). Flow effects on prostacyclin production by cultured human endothelial cells. Science (New York, NY 227, 1477-1479. Gerthoffer, W.T. (2007). Mechanisms of vascular smooth muscle cell migration. Circulation research 100, 607-621. Gow, A.J. (2005). Nitric oxide, hemoglobin, and hypoxic vasodilation. American Journal of Respiratory cell and Molecular Biology 32, 479-482. Greenwood, J.A., Theibert, A.B., Prestwich, G.D., and Murphy-Ullrich, J.E. (2000). Restructuring of focal adhesion plaques by PI 3-kinase. Regulation by PtdIns (3,4,5)-p(3) binding to alpha-actinin. The Journal of Cell Biology 150, 627-642. Grey, S.T., Csizmadia, V., and Hancock, W.W. (1998). Differential effect of tumor necrosis factor-alpha on thrombomodulin gene expression by human monocytoid (THP-1) cell versus endothelial cells. International Journal of Hematology 67, 53-62. Haghighipour, N., Tafazzoli-Shadpour, M., Shokrgozar, M.A., Amini, S., Amanzadeh, A., and Khorasani, M.T. (2007). Topological remodeling of cultured endothelial cells by characterized cyclic strains. Mol Cell Biomech 4, 189-199. Hamada, H., Ishii, H., Sakyo, K., Horie, S., Nishiki, K., and Kazama, M. (1995). The epidermal growth factor-like domain of recombinant human thrombomodulin exhibits mitogenic activity for Swiss 3T3 cells. Blood 86, 225-233. Hansson, G.K. (2005). Inflammation, atherosclerosis, and coronary artery disease. The New England Journal of Medicine 352, 1685-1695. Hennig, B., and Boissonneault, G.A. (1987). Cholestan-3 beta,5 alpha,6 beta-triol decreases barrier function of cultured endothelial cell monolayers. Atherosclerosis 68, 255-261. Hirokawa, K., and Aoki, N. (1991). Regulatory mechanisms for thrombomodulin expression in human umbilical vein endothelial cells in vitro. Journal of Cellular physiology 147, 157-165. Hobson, B., and Denekamp, J. (1984). Endothelial proliferation in tumours and normal tissues: continuous labelling studies. British Journal of Cancer 49, 405-413. Horie, S., Ishii, H., Matsumoto, F., Kusano, M., Kizaki, K., Matsuda, J., and Kazama, M. (2001). Acceleration of thrombomodulin gene transcription by retinoic acid: retinoic acid receptors and Sp1 regulate the promoter activity through interactions with two different sequences in the 5'-flanking region of human gene. The Journal of Biological Chemistry 276, 2440-2450. Iino, S., Abeyama, K., Kawahara, K., Yamakuchi, M., Hashiguchi, T., Matsukita, S., Yonezawa, S., Taniguchi, S., Nakata, M., Takao, S., et al. (2004). The antimetastatic role of thrombomodulin expression in islet cell-derived tumors and its diagnostic value. Clin Cancer Res 10, 6179-6188. Ishii, H., Nakano, M., Tsubouchi, J., Ishikawa, T., Uchiyama, H., Hiraishi, S., Tahara, C., Miyajima, Y., and Kazama, M. (1990). Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies. Thrombosis and Haemostasis 63, 157-162. Ishii, H., Tezuka, T., Ishikawa, H., Takada, K., Oida, K., and Horie, S. (2003). Oxidized phospholipids in oxidized low-density lipoprotein down-regulate thrombomodulin transcription in vascular endothelial cells through a decrease in the binding of RARbeta-RXRalpha heterodimers and Sp1 and Sp3 to their binding sequences in the TM promoter. Blood 101, 4765-4774. Kay, B.K., Williamson, M.P., and Sudol, M. (2000). The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains. Faseb J 14, 231-241. Kinlay, S., Libby, P., and Ganz, P. (2001). Endothelial function and coronary artery disease. Current opinion in lipidology 12, 383-389. Kosonen, O., Kankaanranta, H., Uotila, J., and Moilanen, E. (2000). Inhibition by nitric oxide-releasing compounds of E-selectin expression in and neutrophil adhesion to human endothelial cells. European Journal of Pharmacology 394, 149-156. Koyama, T., Parkinson, J.F., Aoki, N., Bang, N.U., Muller-Berghaus, G., and Preissner, K.T. (1991). Relationship between post-translational glycosylation and anticoagulant function of secretable recombinant mutants of human thrombomodulin. British Journal of Haematology 78, 515-522. Kwon, M.S., Hori, T., Okada, M., and Fukagawa, T. (2007). CENP-C Is Involved in Chromosome Segregation, Mitotic Checkpoint Function, and Kinetochore Assembly. Molecular Biology of the Cell 18, 2155-2168. Lager, D.J., Callaghan, E.J., Worth, S.F., Raife, T.J., and Lentz, S.R. (1995). Cellular localization of thrombomodulin in human epithelium and squamous malignancies. The American Journal of Pathology 146, 933-943. Lahera, V., Goicoechea, M., de Vinuesa, S.G., Miana, M., de las Heras, N., Cachofeiro, V., and Luno, J. (2007). Endothelial dysfunction, oxidative stress and inflammation in atherosclerosis: beneficial effects of statins. Current Medicinal Chemistry 14, 243-248. Langille, B.L. (1996). Arterial remodeling: relation to hemodynamics. Canadian journal of Physiology and Pharmacology 74, 834-841. Laughlin, M.H., Newcomer, S.C., and Bender, S.B. (2008). Importance of hemodynamic forces as signals for exercise-induced changes in endothelial cell phenotype. J Appl Physiol 104, 588-600. Lee, J.O., Yang, H., Georgescu, M.M., Di Cristofano, A., Maehama, T., Shi, Y., Dixon, J.E., Pandolfi, P., and Pavletich, N.P. (1999). Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99, 323-334. Li, D.M., and Sun, H. (1997). TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer research 57, 2124-2129. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S.I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997). PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (New York, NY) 275, 1943-1947. Li, Y.H., Liu, S.L., Shi, G.Y., Tseng, G.H., Liu, P.Y., Wu, H.L. (2006) Thrombomodulin plays an important role in arterial remodeling and neointima formation in mouse carotid ligation model. Thrombosis and Haemostasis 95, 128-133. Libby, P. (2001). Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104, 365-372. Libby, P. (2002). Inflammation in atherosclerosis. Nature 420, 868-874. Libby, P., Ridker, P.M., and Maseri, A. (2002). Inflammation and atherosclerosis. Circulation 105, 1135-1143. Liliental, J., Moon, S.Y., Lesche, R., Mamillapalli, R., Li, D., Zheng, Y., Sun, H., and Wu, H. (2000). Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases. Current Biology 10, 401-404. Lin, Z., Hamik, A., Jain, R., Kumar, A., and Jain, M.K. (2006). Kruppel-like factor 2 inhibits protease activated receptor-1 expression and thrombin-mediated endothelial activation. Arteriosclerosis, Thrombosis, and Vascular Biology 26, 1185-1189. Lloyd-Jones, D.M., Larson, M.G., Beiser, A., and Levy, D. (1999). Lifetime risk of developing coronary heart disease. Lancet 353, 89-92. Lusis, A.J. (2000). Atherosclerosis. Nature 407, 233-241. Malek, A.M., Alper, S.L., and Izumo, S. (1999). Hemodynamic shear stress and its role in atherosclerosis. Journal of the American Medical Association 282, 2035-2042. Malek, A.M., Jackman, R., Rosenberg, R.D., and Izumo, S. (1994). Endothelial expression of thrombomodulin is reversibly regulated by fluid shear stress. Circulation Research 74, 852-860. Marathe, S., Kuriakose, G., Williams, K.J., and Tabas, I. (1999). Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix. Arteriosclerosis, Thrombosis, and Vascular Biology 19, 2648-2658. Marshall, H.E., Merchant, K., and Stamler, J.S. (2000). Nitrosation and oxidation in the regulation of gene expression. Faseb J 14, 1889-1900. Maruyama, I., Bell, C.E., and Majerus, P.W. (1985). Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta. The Journal of Cell Biology 101, 363-371. Mazzone, T., Jensen, M., and Chait, A. (1983). Human arterial wall cells secrete factors that are chemotactic for monocytes. Proceedings of the National Academy of Sciences of the United States of America 80, 5094-5097. Michel, T., and Feron, O. (1997). Nitric oxide synthases: which, where, how, and why? The Journal of Clinical Investigation 100, 2146-2152. Mocellin, S., Bronte, V., and Nitti, D. (2007). Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Medicinal Research Reviews 27, 317-352. Moore, K.L., Esmon, C.T., and Esmon, N.L. (1989). Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood 73, 159-165. Myers, M.P., Pass, I., Batty, I.H., Van der Kaay, J., Stolarov, J.P., Hemmings, B.A., Wigler, M.H., Downes, C.P., and Tonks, N.K. (1998). The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proceedings of the National Academy of Sciences of the United States of America 95, 13513-13518. Myers, M.P., Stolarov, J.P., Eng, C., Li, J., Wang, S.I., Wigler, M.H., Parsons, R., and Tonks, N.K. (1997). P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proceedings of the National Academy of Sciences of the United States of America 94, 9052-9057. Ohji, T., Urano, H., Shirahata, A., Yamagishi, M., Higashi, K., Gotoh, S., and Karasaki, Y. (1995). Transforming growth factor beta 1 and beta 2 induce down-modulation of thrombomodulin in human umbilical vein endothelial cells. Thrombosis and Haemostasis 73, 812-818. Ortiz, P.A., and Garvin, J.L. (2003). Trafficking and activation of eNOS in epithelial cells. Acta Physiologica Scandinavica 179, 107-114. Qiao, J.H., Tripathi, J., Mishra, N.K., Cai, Y., Tripathi, S., Wang, X.P., Imes, S., Fishbein, M.C., Clinton, S.K., Libby, P., et al. (1997). Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. The American Journal of Pathology 150, 1687-1699. Raife, T.J., Lager, D.J., Madison, K.C., Piette, W.W., Howard, E.J., Sturm, M.T., Chen, Y., and Lentz, S.R. (1994). Thrombomodulin expression by human keratinocytes. Induction of cofactor activity during epidermal differentiation. The Journal of Clinical Investigation 93, 1846-1851. Rosenfeld, C.S. (1992). Effects of L-leucyl-L-leucine methyl ester on human marrow and protection of progenitor cells by IL-1. International Journal of Cell Cloning 10, 249-253. Ross, R. (1999). Atherosclerosis--an inflammatory disease. The New England Journal of Medicine 340, 115-126. Ruhul, A., Katherine, C.S., Shou-Ching, S., William, C.A. (2007). NADPH oxidase activity selectively modulates vascular endothelial growth factor signaling pathways. The Journal of Biological Chemistry 282, 35373-35385. Sandusky, G., Berg, D.T., Richardson, M.A., Myers, L., and Grinnell, B.W. (2002). Modulation of thrombomodulin-dependent activation of human protein C through differential expression of endothelial Smads. The Journal of Biological Chemistry 277, 49815-49819. Sato, Y., Hamanaka, R., Ono, J., Kuwano, M., Rifkin, D.B., and Takaki, R. (1991). The stimulatory effect of PDGF on vascular smooth muscle cell migration is mediated by the induction of endogenous basic FGF. Biochemical and Biophysical Research Communications 174, 1260-1266. Shen, W.H., Balajee, A.S., Wang, J., Wu, H., Eng, C., Pandolfi, P.P., and Yin, Y. (2007). Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 128, 157-170. Smith, D.M., Benaroudj, N., and Goldberg, A. (2006). Proteasomes and their associated ATPases: a destructive combination. Journal of Structural Biology 156, 72-83. Steck, P.A., Pershouse, M.A., Jasser, S.A., Yung, W.K., Lin, H., Ligon, A.H., Langford, L.A., Baumgard, M.L., Hattier, T., Davis, T., et al. (1997). Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genetics 15, 356-362. Stephens, N.G., Parsons, A., Schofield, P.M., Kelly, F., Cheeseman, K., and Mitchinson, M.J. (1996). Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347, 781-786. Shi, C.S., Shi, G.Y., Chang, Y.S., Han, H.S., Kuo, C.H., Liu, C., Huang, H.C., Chang, Y.J., Chen, P.S., Wu, H.L. (2005). Evidence of human thrombomodulin domain as a novel angiogenic factor. Circulation 111, 1627-1636. Sumpio, B.E., Banes, A.J., Link, G.W., and Iba, T. (1990). Modulation of endothelial cell phenotype by cyclic stretch: inhibition of collagen production. The Journal of Surgical Research 48, 415-420. Sun, L., and Chen, Z.J. (2004). The novel functions of ubiquitination in signaling. Current Opinion in Cell Biology 16, 119-126. Tanja, W. Sara, S., Lorenza, P., Simona, P. (2007) The ubiquitination code: a signalling problem. Cell Division, 2:11 Toda, M., Yamamoto, K., Shimizu, N., Obi, S., Kumagaya, S., Igarashi, T., Kamiya, A., and Ando, J. (2008). Differential gene responses in endothelial cells exposed to a combination of shear stress and cyclic stretch. Journal of Biotechnology 133, 239-244. Tohda, G., Oida, K., Okada, Y., Kosaka, S., Okada, E., Takahashi, S., Ishii, H., and Miyamori, I. (1998). Expression of thrombomodulin in atherosclerotic lesions and mitogenic activity of recombinant thrombomodulin in vascular smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology 18, 1861-1869. Torres, J., and Pulido, R. (2001). The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. The Journal of Biological Chemistry 276, 993-998. Trotman, L.C., Wang, X., Alimonti, A., Chen, Z., Teruya-Feldstein, J., Yang, H., Pavletich, N.P., Carver, B.S., Cordon-Cardo, C., Erdjument-Bromage, H., et al. (2007). Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 128, 141-156. Van de Wouwer, M., and Conway, E.M. (2004). Novel functions of thrombomodulin in inflammation. Critical Care Medicine 32, S254-261. Varshavsky, A. (2005). Regulated protein degradation. Trends in Biochemical Sciences 30, 283-286. Waite, K.A., and Eng, C. (2002). Protean PTEN: form and function. American Journal of Human Genetics 70, 829-844. Weiler, H. (2004). Mouse models of thrombosis: thrombomodulin. Thrombosis and Haemostasis 92, 467-477. Weiler, H., Lindner, V., Kerlin, B., Isermann, B.H., Hendrickson, S.B., Cooley, B.C., Meh, D.A., Mosesson, M.W., Shworak, N.W., Post, M.J., et al. (2001). Characterization of a mouse model for thrombomodulin deficiency. Arteriosclerosis, Thrombosis, and Vascular Biology 21, 1531-1537. Weisel, J.W., Nagaswami, C., Young, T.A., and Light, D.R. (1996). The shape of thrombomodulin and interactions with thrombin as determined by electron microscopy. The Journal of Biological Chemistry 271, 31485-31490. Weng, L., Brown, J., and Eng, C. (2001). PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways. Human Molecular Genetics 10, 237-242. Wu, R., Huang, Y.H., Elinder, L.S., and Frostegard, J. (1998). Lysophosphatidylcholine is involved in the antigenicity of oxidized LDL. Arteriosclerosis, Thrombosis, and Vascular Biology 18, 626-630. Wu, X., Hepner, K., Castelino-Prabhu, S., Do, D., Kaye, M.B., Yuan, X.J., Wood, J., Ross, C., Sawyers, C.L., and Whang, Y.E. (2000). Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proceedings of the National Academy of Sciences of the United States of America 97, 4233-4238. Yang, L., Manithody, C., Walston, T.D., Cooper, S.T., and Rezaie, A.R. (2003). Thrombomodulin enhances the reactivity of thrombin with protein C inhibitor by providing both a binding site for the serpin and allosterically modulating the activity of thrombin. The Journal of Biological Chemistry 278, 37465-37470. Yun, J.K., Anderson, J.M., and Ziats, N.P. (1999). Cyclic-strain-induced endothelial cell expression of adhesion molecules and their roles in monocyte-endothelial interaction. Journal of Biomedical Materials Research 44, 87-97. 王安姬 (2006). 內皮細胞中凝血酶調節素TM及轉錄因子KLF2受剪力調控及其訊息傳遞路徑之探討 (國立台灣大學化學工程研究所碩士學位論文). 謝宗祐 (2007). 剪力調控內皮細胞中凝血酶調節素之訊息傳導路徑及其蛋白質穩定性之調節 (國立台灣大學化學工程研究所碩士學位論文). 蕭錫閩 (2005). 凝血酶調節素各功能區域對於抗發炎反應之探討 (國立成功大學生物化學暨分子生物研究所碩士論文) | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/40282 | - |
| dc.description.abstract | 動脈粥狀硬化致病過程中,發炎反應(inflammation)與凝血反應扮演十分重要的角色。而在血管內皮細胞中的凝血酶調節素(thrombomodulin;簡稱TM)具有抗凝血及抗發炎的功能,近年來亦被發現具有調控細胞遷移與內皮細胞血管新生的效果。由於血管中血液脈動產生的壓力變化會對內皮細胞產生拉伸應力,進而調控內皮細胞的生理功能。本研究使用人類臍帶靜脈內皮細胞(HUVECs)與牛大主動脈內皮細胞(BAECs),探討拉伸應力刺激誘發細胞中TM的訊息傳遞路徑;另外也對TM蛋白質穩定性之調控機制進行研究。
當內皮細胞受到靜態拉伸應力刺激時,TM的mRNA量有顯著增加,在一小時內增加到控制組的3.2倍,但在六小時後又降至與控制組無異。顯示在拉伸應力的作用下,TM mRNA的轉錄效率在一小時內很快的上昇。但此效果屬於暫態誘發 (transient induction),並無法持續地刺激TM mRNA的轉錄。而在蛋白質層面上,TM蛋白質量亦因為受到拉伸應力的作用而增加達2.2倍以上,且可以至少持續六小時。另外在對細胞做螢光染色後,發現拉伸應力可以促使TM與細胞骨架actin有共位(colocolization),使TM在細胞中呈現類似stress fiber的特殊分佈。 關於TM蛋白質穩定性的探討,實驗使用短效型及長效型NO donor(分別為SNAP及NOC18)模擬eNOS受拉伸應力活化而釋放NO的效果,並且轉染在C端帶有FLAG作為標記的TM質體觀察TM的降解情形。結果發現NO在短時間內可以抑制TM蛋白質的降解,而在長時間下NO對TM穩定性的影響不大。 接著探討TM胞內區域磷酸化/去磷酸化對TM蛋白質穩定性的影響,實驗以VEGF刺激細胞內的蛋白激酶及以protein tyrosine phosphatase (PTP) inhibitor(Na3VO4),發現抑制PTP會增加TM的降解而VEGF則沒有明顯的作用,為了證實Y534位置的磷酸化影響TM的穩定性,本研究利用無法磷酸化的Y534A TM變異種來進行實驗。而當胞內區域的Y534位置突變成alanine則幾乎不產生TM的降解片段。顯示TM胞內區域Y534位置經常地受到去磷酸酶的作用,一但抑制了去磷酸酶TM立即遭到降解,而此降解的機制可能是經由泛素化的標記,進而被proteasome降解,實驗顯示TM胞內區域的threonine550以及tyrosine534位置若被磷酸化會造成泛素化的機會增加。 在探討PTP對TM的作用方式之中,以免疫沉澱法沉澱出與TM有association的蛋白質,發現其中有PTEN的存在,顯示TM 於一般狀態下即會與PTEN有association,但此作用並不受細胞內的NO與ROS影響。 综合以上的實驗結果歸納拉伸應力對TM的調控以及影響TM穩定性的可能機制。當內皮細胞受到拉伸應力作用時,在短時間內會增加TM mRNA的表現,並增加TM蛋白質的穩定性,增加細胞內一氧化氮量可以抑制TM的降解。當PTEN對TM胞內區域進行去磷酸化會增加TM穩定性,使其不易受到降解,反之,當胞內區域的的Y534位置磷酸化增加將會受到泛素化,最終被proteasome降解。另外當細胞受到拉伸應力的作用將會增加TM與actin的共位(colocalization),使TM在細胞中呈現類似stress fiber的特殊分布情形。 | zh_TW |
| dc.description.abstract | During atherogenesis, inflammation and coagulation play an important role. Thrombomodulin (TM), in vascular endothelial cells, has anti-coagulation and anti-inflammation properties. It can also regulate cell migration and angiogenesis. Vascular Endothelial cells (ECs) are exposed to stretch caused by the blood pressure. Therefore, stretch is an important regulator of EC functions. In this study, human umbilical vein endothelial cells (HUVECs) and bovine aortic endothelial cells (BAECs) were utilized to investigate the signaling pathway of stretch-induced TM and the regulatory mechanism of TM protein stability.
When ECs were exposed to stretch (16% strain) for 1 hour, the mRNA level of TM was increased more than 3.2 folds in comparison with static control, but decreased to the same level as that of static control after 6 hours. These results suggest that stretch transiently induces the mRNA level of TM. As for TM protein level, stretch also induced the protein level of TM up to 2.2 folds, and this effect sustained at least for 6 hours. On the other hand, Double immunofluorescence staining for TM and actin showed that the colocalization between TM and actin was induced by stretch, which led to the special distribution of TM in ECs. We further transfected ECs with TM plasmid containing C-terminal FLAG tag to explore the regulatory mechanism of TM stability. To simulate the condition of stretch-induced nitric oxide (NO) release, ECs were treated with short term and long term NO donor (SNAP and NOC18, respectively), and we found that only short term NO donor protected TM protein from degradation.. To explore the effect of phosphorylation/dephosphorylation on the stability of TM, VEGF and protein tyrosine phosphatase (PTP) inhibitor (Na3VO4) were used. We found that inhibition of PTP activity by Na3VO4 increased the degradation of TM, whereas the use of VEGF to stimulate kinase activity had no effect on the TM stability. These results suggest that the phosphorylation of C-terminal tyrosine residue (Y534) of TM may regulate the TM protein stability. To verify this assumption, Y534A mutant of TM plasmid was transfected into BAECs. We found that in cells transfected with Y534A there was no degradation fragment of TM. Therefore, it is likely that the C-terminal Y534 residue of TM is constantly dephosphorylated by PTP and the dephosphorylation of Y534 residue may stabilize TM protein. Futhermore, our data showed that ubiquitination may play a role in the degradation of TM. Then we used immunoprecipitation to find out that PTEN was associated with TM under normal condition. NO and H2O2 had slight effect on the association between TM and PTEN. In summary, our data suggest that stretch transiently up-regulates the mRNA level of TM. Stretch also upregulates the protein level of TM, and the effect sustains at least for 6 hours. Besides, stretch increases the colocalization between TM and actin and leads to the special distribution of TM in ECs. Further studies indicate that NO may protect TM from degradation. PTEN may dephosphorylate TM Y534 residue and thus stabilize TM protein. On the contrary, the increase in Y534 phosphorylation may lead to the degradation of TM through ubiquitin proteasome system. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-14T16:43:59Z (GMT). No. of bitstreams: 1 ntu-97-R95524075-1.pdf: 4722239 bytes, checksum: 0ad3d1613203c046b0dece0a53bb5eb4 (MD5) Previous issue date: 2008 | en |
| dc.description.tableofcontents | 誌謝 I
中文摘要 III Abstract V 目錄 VII 圖目錄 IX 表目錄 XI 縮寫與符號說明 XIII 中英名詞對照 XVII 1. 緒論 1 1.1. 動脈粥狀硬化(Atherosclerosis) 1 1.2. 研究動機與目的 7 2. 文獻回顧 9 2.1. 血管內皮細胞與拉伸應力 9 2.1.1. 血管內皮細胞 9 2.1.2. 拉伸應力對於內皮細胞的影響 13 2.2. 凝血酶調節素(Thrombomodulin, TM) 15 2.2.1. TM之結構與生理功能 15 2.2.2. TM對發炎機制與凝血機制之調控 20 2.2.3. TM對細胞附著、血管新生及細胞遷移之調控 23 2.2.4. TM表現量之調控 25 2.3. PTEN(Phosphatase and tensin homolog deleted on chromosome 10) 28 2.3.1. PTEN之結構 28 2.3.2. PTEN在生理功能上扮演的角色 31 2.4. 一氧化氮(NO)對於內皮細胞之調控 36 2.5. 泛素化 41 3. 實驗藥品、儀器及方法 43 3.1. 實驗材料 43 3.1.1. 細胞培養所用材料 43 3.1.2. 實驗耗材 45 3.1.3. 細胞轉染所使用之材料 45 3.1.4. 西方墨點轉印法所用之材料 47 3.1.5. 免疫螢光染色法所用之材料 48 3.1.6. 同步定量聚合酶連鎖反應(Real-time Quantitative PCR) 48 3.2. 實驗儀器 49 3.3. 實驗原理與方法 51 3.3.1. 初級人類臍帶靜脈內細胞培養 51 3.3.2. 人類臍帶靜脈內皮細胞繼代培養於PDMS 52 3.3.3. 人類臍帶靜脈內皮細胞繼代培養於培養皿 52 3.3.4. 牛動脈內皮細胞繼代培養 53 3.3.5. 細胞拉伸實驗之設計 54 3.3.6. 全溶胞產物(total cell lysate)之蛋白質的抽取 56 3.3.7. 蛋白質含量測定 56 3.3.8. 免疫沉澱法(Immunoprecipitation) 57 3.3.9. 細胞內特定蛋白質含量測定(Western Blot) 57 3.3.10. 細胞內全RNA(total RNA)的收取 59 3.3.11. 細胞內特定mRNA含量測定:Real-Time quantitiative PCR 59 3.3.12. 免疫螢光染色法(Immunofluorescence) 61 4. 結果與討論 63 4.1. 拉伸應力對於TM之影響 63 4.1.1. 拉伸應力對TM mRNA之影響 63 4.1.2. 拉伸應力對TM 蛋白質之影響 65 4.1.3. 拉伸應力對TM 蛋白質分佈之影響 68 4.2. 一氧化氮(NO)對於TM穩定性之影響 70 4.3. 蛋白質酪胺酸去磷酸酶(PTP)對TM穩定性之調控 74 4.4. 泛素化對於TM穩定性之影響 77 4.5. PTEN直接作用於TM之胞內區域 79 4.6. 綜合討論 82 5. 結論 87 5.1. 結論 87 5.2. 未來研究方向 89 參考文獻 91 | |
| dc.language.iso | zh-TW | |
| dc.subject | 調節素 | zh_TW |
| dc.subject | 凝血酶 | zh_TW |
| dc.subject | 內皮細胞 | zh_TW |
| dc.subject | 拉伸應力 | zh_TW |
| dc.subject | thrombomodulin | en |
| dc.subject | endothelial cell | en |
| dc.subject | stretch | en |
| dc.title | 拉伸應力對內皮細胞中凝血酶調節素之調控 | zh_TW |
| dc.title | Regulation of Thrombomodulin in Endothelial Cells by Stretch | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 96-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.coadvisor | 王 寧(Danny-Ling Wang) | |
| dc.contributor.oralexamcommittee | 吳華林 | |
| dc.subject.keyword | 內皮細胞,凝血酶,調節素,拉伸應力, | zh_TW |
| dc.subject.keyword | endothelial cell,thrombomodulin,stretch, | en |
| dc.relation.page | 99 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2008-08-01 | |
| dc.contributor.author-college | 工學院 | zh_TW |
| dc.contributor.author-dept | 化學工程學研究所 | zh_TW |
| 顯示於系所單位: | 化學工程學系 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-97-1.pdf 未授權公開取用 | 4.61 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
